1. True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature
   Chiara Nicolazzo et al, 2021, Cancer Letters CrossRef
2. Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer
   Federica Cosso et al, 2023, Anti-Cancer Drugs CrossRef
3. Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients
   Daniele Lavacchi et al, 2023, Heliyon CrossRef
4. Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer
   Daniele Lavacchi et al, 2022, Frontiers in Oncology CrossRef
5. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer
   Isabel Heidrich et al, 2021, Cancers CrossRef
6. Concordance between the tumor mutational status and circulating tumor DNA in patients with colorectal cancer
   E. M. Polyanskaya et al, 2022, Pelvic Surgery and Oncology CrossRef
7. Evaluation of RAS Mutational Status in Liquid Biopsy to Monitor Disease Progression in Metastatic Colorectal Cancer Patients
   Elena Lastraioli et al, 2023, Cells CrossRef